U.S. patent number D462,760 [Application Number D/143,407] was granted by the patent office on 2002-09-10 for medication delivery apparatus. This patent grant is currently assigned to Eli Lilly and Company. Invention is credited to Dirk Ahlgrim, Bradley R. Newman, Gerd Schmieta, Dana Lea Schuch.
United States Patent | D462,760 |
Ahlgrim , et al. | September 10, 2002 |
Inventors: | Ahlgrim; Dirk (Boston, MA), Newman; Bradley R. (Avon, IN), Schmieta; Gerd (Boston, MA), Schuch; Dana Lea (Fishers, IN) |
---|---|
Assignee: | Eli Lilly and Company
(Indianapolis, IN) |
Appl. No.: | D/143,407 |
Filed: | June 13, 2001 |
Current U.S. Class: | D24/114; D24/112 |
Current International Class: | 2402 |
Field of Search: | ;D24/114,113,112,147 ;D19/43,51 ;604/506,211,218,156,207,198,137,134,136,132,135,187 |
4973318 | November 1990 | Holm et al. |
5042977 | August 1991 | Bechtold et al. |
D330079 | October 1992 | Dalling et al. |
5226895 | July 1993 | Harris |
5226896 | July 1993 | Harris |
5279586 | January 1994 | Balkwill |
5383865 | January 1995 | Michel |
5545147 | August 1996 | Harris |
5626566 | May 1997 | Petersen et al. |
5645534 | July 1997 | Chanoch |
5688251 | November 1997 | Chanoch |
5820602 | October 1998 | Kovelman et al. |
5925021 | July 1999 | Castellano et al. |
5957896 | September 1999 | Bendek et al. |
6001089 | December 1999 | Burroughs et al. |
6048336 | April 2000 | Gabriel |
D426299 | June 2000 | Bydlon et al. |
6193698 | February 2001 | Kirchhofer et al. |
6277099 | August 2001 | Strowe et al. |
0 937 472 | Aug 1999 | EP | |||
1 095 668 | Oct 2000 | EP | |||
98/10814 | Mar 1998 | WO | |||
99/43283 | Sep 1999 | WO | |||
01/10484 | Feb 2001 | WO | |||
"An unsurpassed range NovoPen.RTM. 3" brochure from Novo Nordisk, dated Sep. 1999. . Brochure in Japanese from Eli Lilly and Company dated 1999. . "NovoLet.RTM.--The World's First Prefilled Insulin Syringe" brochure from Novo Nordisk. . "Lantus.RTM. OptiSet.RTM." brochure from Aventis. . "Die Optipen.RTM. Familie" brochure from Aventis. . "Innovo.RTM.--New generation design in insulin delivery" brochure from Novo Nordisk, dated Jun. 2000. . "New InnoLet.RTM." brochure from Novo Nordisk.. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.